RxDoctor Payments DataLook up a doctor →

Carlos Leon, MD

Nephrology · St George, UTNPI 1932131869

Payments from drug & device makers

$251,796in general payments, 2019–2025

Across 336 payments — averaging $749.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Akebia Therapeutics Inc$111K
  • AstraZeneca$43K
  • Bayer$30K
  • Astrazeneca UK Limited$27K
  • Boehringer Ingelheim$18K
  • Biogen$7K
  • plus $16K from 33 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Akebia Therapeutics Inc92$110,507
AstraZeneca(2 entities)37$43,447
Bayer26$30,030
Astrazeneca UK Limited3$27,453
Boehringer Ingelheim7$17,504
Biogen1$6,806
Ardelyx, Inc.8$4,320
Alnylam Pharmaceuticals Inc.3$3,520
Boehringer Ingelheim Limited1$2,356
AbbVie1$2,149
Amgen(2 entities)31$642
Travere Therapeutics, Inc.16$410
GSK13$292
OPKO Pharmaceuticals, LLC13$261
Otsuka America Pharmaceutical, Inc.13$252
Calliditas Therapeutics US Inc.10$244
Genentech USA, Inc.5$238
Vifor Pharma, Inc.9$178
Mallinckrodt Hospital Products Inc.9$176
Bard Peripheral Vascular, Inc.3$135
Organogenesis Inc.1$118
ANI Pharmaceuticals, Inc.4$97
Takeda Pharmaceuticals U.S.A., Inc.3$75
KCI USA, Inc.1$59
Bioventus LLC1$58
Fresenius USA Marketing, Inc.3$53
Johnson & Johnson1$52
Novartis3$48
Daiichi Sankyo Inc.3$48
Lilly USA, LLC2$45
Regeneron Healthcare Solutions, Inc.3$45
Shire North American Group Inc2$36
Aurinia Pharma U.S., Inc.2$34
Sanofi-aventis U.S. LLC1$24
Mallinckrodt Enterprises LLC1$21
Ascendis Pharma Endocrinology Inc1$19
Cormedix Inc.1$16
Medtronic1$15
Sanofi1$14

How this compares

$251,796 in reported general payments places this provider in the 90th percentile of 74 nephrology providers in Utah.

See all nephrology providers in Utah →

Medicare billing

Part B allowed, 2024
$198,720
Medicare patients
512
Services billed
2,004

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other nephrology in St George

See the full list for Utah →

Where these figures come from

Is this you, or does something look wrong? →